The Drug Eluting Balloon Market was valued at USD 1.17 Bn in 2024, and total global Drug Eluting Balloon Market revenue is expected to grow at a CAGR of 8.0% and reach nearly USD 2.17 Bn from 2025-2032, driven by cardiovascular cases, minimally invasive, coating tech. Drug Eluting Balloons (DEB) are conventional semi-compliant angioplasty balloons coated with an anti-proliferative drug, which is released into vessel wall during inflation of the balloon, generally at nominal pressures with a precise minimal inflation time. Drug eluting balloon plays an important role in modern healthcare, as it delivers medication and prevents neointimal hyperplasia.To know about the Research Methodology:-Request Free Sample Report Increasing occurrence of coronary artery diseases among people across the globe is a key factor expected to drive the growth of the global market over the forecast period. According to the World Health Organization (WHO), about 17.9 Mn people die, every year caused by coronary heart disease across the globe. Besides, increasing the prevalence of diabetes is another factor expected to further fuel the growth of the market over the forecast period. For instance, according to WHO, in October 2021 reported over 1.6 Mn deaths are registered, which are caused by diabetes across globe. Furthermore, rising manufacturer’s inclination towards acquisition strategies to develop innovative products and expand their product portfolio is another factor expected to boost the growth of the market over the forecast period. Also, the presence of major players operating in the market, such as Medtronic, Inc. and Boston Scientific Corporation and increasing R&D activities for drug eluting balloon is another factor, expected to boost the growth of the market in a certain extent. However, adverse effects such as lumen enlargement and coronary artery lesions are expected to restrain the growth of the global market over the forecast period. For instance, in May 2021, Abbott Laboratory recalled three balloon catheters due to problems faced while removing balloon sheath, which caused 19 incidences of injury and 1 death.
Drug Eluting Balloon Market Segment Analysis
Based on technology, the drug-eluting balloon market is segmented into Paccocath, FreePac, TransPax, EnduraCoat, and others. Among these, Paccocath technology dominated due to its superior drug delivery efficiency and proven clinical outcomes in treating peripheral and coronary artery diseases. FreePac and TransPax technologies are gaining traction owing to their enhanced coating methods that ensure uniform drug release and reduced restenosis rates. EnduraCoat is known for its durability and controlled drug release, making it suitable for complex cases. Based on end-user, the drug eluting balloon market is segmented into hospitals & ambulatory surgery centers, cath laboratories, specialty clinics, and others. Hospitals and ambulatory surgery centers hold the largest market share due to the growing number of cardiovascular procedures and availability of advanced infrastructure. Cath laboratories are increasingly adopting drug eluting balloons because of their minimally invasive nature and precise treatment delivery. Specialty clinics cater to outpatient care and are expanding due to rising demand for faster, cost-effective interventions. According to the product type segments, the peripheral drug eluting balloon segment is expected to dominate in the market in terms of revenue over the forecast period, also on account of increasing use of drug eluting balloon for treatment of peripheral artery diseases. Region-wise, the market in North America is expected to leading in the global market in terms of revenue over the forecast period, thanks to the increasing prevalence of cardiovascular diseases and obesity across several countries in the region over the forecast period. The objective of the report is to present a comprehensive analysis of the Global market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by Application. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by Application on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global market dynamics, structure by analyzing the market segments and project the Global market size. Clear representation of competitive analysis of key players by Type, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Drug Eluting Balloon Market make the report investor’s guide. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.Drug Eluting Balloon Market Scope: Inquire before buying
Global Drug Eluting Balloon Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 1.17 Bn. Forecast Period 2025 to 2032 CAGR: 8.0% Market Size in 2032: USD 2.17 Bn. Segments Covered: by Product Type Coronary Drug-Eluting Balloons Peripheral Drug-Eluting Balloons Others by Drug Type Paclitaxel Sirolimus Others by Technology Paccocath FreePac TransPax EnduraCoat Others by Application Coronary Artery Disease (CAD) Peripheral Artery Disease (PAD) Others by End User Hospitals & Ambulatory Surgery Centers Cath Laboratories Specialty Clinics Others Drug Eluting Balloon Market, by Region
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, Rest of Asia Pacific) Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A) South America (Brazil, Argentina, Rest of South America)Drug Eluting Balloon Market, Key players are:
1. Medtronic, Inc. 2. Becton, Dickinson and Company 3. Boston Scientific Corporation 4. Cook Medical Incorporated 5. Braun Melsungen AG 6. Koninklijke Philips N.V. 7. Opto Circuits (India) Limited 8. Terumo Corporation 9. Surmodics, Inc. 10. Biotronik, Inc. 11. Concept Medical Inc. 12. BIOTRONIK SE & Co. KG 13. Innvolution Healthcare Pvt. Ltd. 14. Medtronic plc 15. Eurocor GmbH 16. C.R. Bard 17. Aachen Resonance GmbH Frequently Asked Questions: 1. Which region has the largest share in Global Drug Eluting Balloon Market? Ans: North America region held the highest share in 2024. 2. What is the growth rate of Global Drug Eluting Balloon Market? Ans: The Global Drug Eluting Balloon Market is growing at a CAGR of 8.0% during forecasting period 2025-2032. 3. What is scope of the Global Drug Eluting Balloon market report? Ans: Global Drug Eluting Balloon Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Drug Eluting Balloon market? Ans: The important key players in the Global Drug Eluting Balloon Market are – Medtronic, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Incorporated, Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., Biotronik, Inc., Concept Medical Inc., BIOTRONIK SE & Co. KG, Innvolution Healthcare Pvt. Ltd., Medtronic plc, Eurocor GmbH, C.R. Bard, and Aachen Resonance GmbH. 5. What is the study period of this market? Ans: The Global Drug Eluting Balloon Market is studied from 2024 to 2032.
1. Drug Eluting Balloon Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Drug Eluting Balloon Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Drug Eluting Balloon Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Drug Eluting Balloon Market: Dynamics 3.1. Drug Eluting Balloon Market Trends by Region 3.1.1. North America Drug Eluting Balloon Market Trends 3.1.2. Europe Drug Eluting Balloon Market Trends 3.1.3. Asia Pacific Drug Eluting Balloon Market Trends 3.1.4. Middle East and Africa Drug Eluting Balloon Market Trends 3.1.5. South America Drug Eluting Balloon Market Trends 3.2. Drug Eluting Balloon Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Drug Eluting Balloon Market Drivers 3.2.1.2. North America Drug Eluting Balloon Market Restraints 3.2.1.3. North America Drug Eluting Balloon Market Opportunities 3.2.1.4. North America Drug Eluting Balloon Market Challenges 3.2.2. Europe 3.2.2.1. Europe Drug Eluting Balloon Market Drivers 3.2.2.2. Europe Drug Eluting Balloon Market Restraints 3.2.2.3. Europe Drug Eluting Balloon Market Opportunities 3.2.2.4. Europe Drug Eluting Balloon Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Drug Eluting Balloon Market Drivers 3.2.3.2. Asia Pacific Drug Eluting Balloon Market Restraints 3.2.3.3. Asia Pacific Drug Eluting Balloon Market Opportunities 3.2.3.4. Asia Pacific Drug Eluting Balloon Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Drug Eluting Balloon Market Drivers 3.2.4.2. Middle East and Africa Drug Eluting Balloon Market Restraints 3.2.4.3. Middle East and Africa Drug Eluting Balloon Market Opportunities 3.2.4.4. Middle East and Africa Drug Eluting Balloon Market Challenges 3.2.5. South America 3.2.5.1. South America Drug Eluting Balloon Market Drivers 3.2.5.2. South America Drug Eluting Balloon Market Restraints 3.2.5.3. South America Drug Eluting Balloon Market Opportunities 3.2.5.4. South America Drug Eluting Balloon Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Drug Eluting Balloon Industry 3.8. Analysis of Government Schemes and Initiatives For Drug Eluting Balloon Industry 3.9. Drug Eluting Balloon Market Trade Analysis 3.10. The Global Pandemic Impact on Drug Eluting Balloon Market 4. Drug Eluting Balloon Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 4.1.1. Coronary Drug-Eluting Balloons 4.1.2. Peripheral Drug-Eluting Balloons 4.1.3. Others 4.2. Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 4.2.1. Paclitaxel 4.2.2. Sirolimus 4.2.3. Others 4.3. Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 4.3.1. Paccocath 4.3.2. FreePac 4.3.3. TransPax 4.3.4. EnduraCoat 4.3.5. Others 4.4. Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 4.4.1. Coronary Artery Disease (CAD) 4.4.2. Peripheral Artery Disease (PAD) 4.4.3. Others 4.5. Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 4.5.1. Hospitals & Ambulatory Surgery Centers 4.5.2. Cath Laboratories 4.5.3. Specialty Clinics 4.5.4. Others 4.6. Drug Eluting Balloon Market Size and Forecast, by Region (2024-2032) 4.6.1. North America 4.6.2. Europe 4.6.3. Asia Pacific 4.6.4. Middle East and Africa 4.6.5. South America 5. North America Drug Eluting Balloon Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 5.1.1. Coronary Drug-Eluting Balloons 5.1.2. Peripheral Drug-Eluting Balloons 5.1.3. Others 5.2. North America Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 5.2.1. Paclitaxel 5.2.2. Sirolimus 5.2.3. Others 5.3. North America Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 5.3.1. Paccocath 5.3.2. FreePac 5.3.3. TransPax 5.3.4. EnduraCoat 5.3.5. Others 5.4. North America Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 5.4.1. Coronary Artery Disease (CAD) 5.4.2. Peripheral Artery Disease (PAD) 5.4.3. Others 5.5. North America Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 5.5.1. Hospitals & Ambulatory Surgery Centers 5.5.2. Cath Laboratories 5.5.3. Specialty Clinics 5.5.4. Others 5.6. North America Drug Eluting Balloon Market Size and Forecast, by Country (2024-2032) 5.6.1. United States 5.6.1.1. United States Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 5.6.1.1.1. Coronary Drug-Eluting Balloons 5.6.1.1.2. Peripheral Drug-Eluting Balloons 5.6.1.1.3. Others 5.6.1.2. United States Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 5.6.1.2.1. Paclitaxel 5.6.1.2.2. Sirolimus 5.6.1.2.3. Others 5.6.1.3. United States Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 5.6.1.3.1. Paccocath 5.6.1.3.2. FreePac 5.6.1.3.3. TransPax 5.6.1.3.4. EnduraCoat 5.6.1.3.5. Others 5.6.1.4. United States Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 5.6.1.4.1. Coronary Artery Disease (CAD) 5.6.1.4.2. Peripheral Artery Disease (PAD) 5.6.1.4.3. Others 5.6.1.5. United States Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 5.6.1.5.1. Hospitals & Ambulatory Surgery Centers 5.6.1.5.2. Cath Laboratories 5.6.1.5.3. Specialty Clinics 5.6.1.5.4. Others 5.6.2. Canada 5.6.2.1. Canada Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 5.6.2.1.1. Coronary Drug-Eluting Balloons 5.6.2.1.2. Peripheral Drug-Eluting Balloons 5.6.2.1.3. Others 5.6.2.2. Canada Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 5.6.2.2.1. Paclitaxel 5.6.2.2.2. Sirolimus 5.6.2.2.3. Others 5.6.2.3. Canada Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 5.6.2.3.1. Paccocath 5.6.2.3.2. FreePac 5.6.2.3.3. TransPax 5.6.2.3.4. EnduraCoat 5.6.2.3.5. Others 5.6.2.4. Canada Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 5.6.2.4.1. Coronary Artery Disease (CAD) 5.6.2.4.2. Peripheral Artery Disease (PAD) 5.6.2.4.3. Others 5.6.2.5. Canada Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 5.6.2.5.1. Hospitals & Ambulatory Surgery Centers 5.6.2.5.2. Cath Laboratories 5.6.2.5.3. Specialty Clinics 5.6.2.5.4. Others 5.6.3. Mexico 5.6.3.1. Mexico Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 5.6.3.1.1. Coronary Drug-Eluting Balloons 5.6.3.1.2. Peripheral Drug-Eluting Balloons 5.6.3.1.3. Others 5.6.3.2. Mexico Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 5.6.3.2.1. Paclitaxel 5.6.3.2.2. Sirolimus 5.6.3.2.3. Others 5.6.3.3. Mexico Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 5.6.3.3.1. Paccocath 5.6.3.3.2. FreePac 5.6.3.3.3. TransPax 5.6.3.3.4. EnduraCoat 5.6.3.3.5. Others 5.6.3.4. Mexico Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 5.6.3.4.1. Coronary Artery Disease (CAD) 5.6.3.4.2. Peripheral Artery Disease (PAD) 5.6.3.4.3. Others 5.6.3.5. Mexico Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 5.6.3.5.1. Hospitals & Ambulatory Surgery Centers 5.6.3.5.2. Cath Laboratories 5.6.3.5.3. Specialty Clinics 5.6.3.5.4. Others 6. Europe Drug Eluting Balloon Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.2. Europe Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.3. Europe Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.4. Europe Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.5. Europe Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6. Europe Drug Eluting Balloon Market Size and Forecast, by Country (2024-2032) 6.6.1. United Kingdom 6.6.1.1. United Kingdom Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.1.2. United Kingdom Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.1.3. United Kingdom Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.1.4. United Kingdom Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.1.5. United Kingdom Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.2. France 6.6.2.1. France Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.2.2. France Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.2.3. France Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.2.4. France Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.2.5. France Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.3. Germany 6.6.3.1. Germany Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.3.2. Germany Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.3.3. Germany Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.3.4. Germany Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.3.5. Germany Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.4. Italy 6.6.4.1. Italy Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.4.2. Italy Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.4.3. Italy Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.4.4. Italy Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.4.5. Italy Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.5. Spain 6.6.5.1. Spain Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.5.2. Spain Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.5.3. Spain Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.5.4. Spain Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.5.5. Spain Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.6. Sweden 6.6.6.1. Sweden Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.6.2. Sweden Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.6.3. Sweden Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.6.4. Sweden Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.6.5. Sweden Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.7. Austria 6.6.7.1. Austria Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.7.2. Austria Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.7.3. Austria Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.7.4. Austria Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.7.5. Austria Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 6.6.8. Rest of Europe 6.6.8.1. Rest of Europe Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 6.6.8.2. Rest of Europe Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 6.6.8.3. Rest of Europe Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 6.6.8.4. Rest of Europe Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 6.6.8.5. Rest of Europe Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7. Asia Pacific Drug Eluting Balloon Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.2. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.3. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.4. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.5. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6. Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Country (2024-2032) 7.6.1. China 7.6.1.1. China Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.1.2. China Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.1.3. China Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.1.4. China Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.1.5. China Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.2. S Korea 7.6.2.1. S Korea Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.2.2. S Korea Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.2.3. S Korea Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.2.4. S Korea Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.2.5. S Korea Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.3. Japan 7.6.3.1. Japan Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.3.2. Japan Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.3.3. Japan Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.3.4. Japan Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.3.5. Japan Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.4. India 7.6.4.1. India Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.4.2. India Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.4.3. India Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.4.4. India Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.4.5. India Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.5. Australia 7.6.5.1. Australia Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.5.2. Australia Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.5.3. Australia Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.5.4. Australia Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.5.5. Australia Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.6. Indonesia 7.6.6.1. Indonesia Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.6.2. Indonesia Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.6.3. Indonesia Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.6.4. Indonesia Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.6.5. Indonesia Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.7. Malaysia 7.6.7.1. Malaysia Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.7.2. Malaysia Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.7.3. Malaysia Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.7.4. Malaysia Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.7.5. Malaysia Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.8. Vietnam 7.6.8.1. Vietnam Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.8.2. Vietnam Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.8.3. Vietnam Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.8.4. Vietnam Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.8.5. Vietnam Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.9. Taiwan 7.6.9.1. Taiwan Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.9.2. Taiwan Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.9.3. Taiwan Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.9.4. Taiwan Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.9.5. Taiwan Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 7.6.10. Rest of Asia Pacific 7.6.10.1. Rest of Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 7.6.10.2. Rest of Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 7.6.10.3. Rest of Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 7.6.10.4. Rest of Asia Pacific Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 7.6.10.5. Rest of Asia Pacific Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 8. Middle East and Africa Drug Eluting Balloon Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 8.2. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 8.3. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 8.4. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 8.5. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 8.6. Middle East and Africa Drug Eluting Balloon Market Size and Forecast, by Country (2024-2032) 8.6.1. South Africa 8.6.1.1. South Africa Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 8.6.1.2. South Africa Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 8.6.1.3. South Africa Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 8.6.1.4. South Africa Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 8.6.1.5. South Africa Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 8.6.2. GCC 8.6.2.1. GCC Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 8.6.2.2. GCC Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 8.6.2.3. GCC Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 8.6.2.4. GCC Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 8.6.2.5. GCC Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 8.6.3. Nigeria 8.6.3.1. Nigeria Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 8.6.3.2. Nigeria Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 8.6.3.3. Nigeria Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 8.6.3.4. Nigeria Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 8.6.3.5. Nigeria Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 8.6.4. Rest of ME&A 8.6.4.1. Rest of ME&A Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 8.6.4.2. Rest of ME&A Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 8.6.4.3. Rest of ME&A Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 8.6.4.4. Rest of ME&A Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 8.6.4.5. Rest of ME&A Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 9. South America Drug Eluting Balloon Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 9.2. South America Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 9.3. South America Drug Eluting Balloon Market Size and Forecast, by Technology(2024-2032) 9.4. South America Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 9.5. South America Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 9.6. South America Drug Eluting Balloon Market Size and Forecast, by Country (2024-2032) 9.6.1. Brazil 9.6.1.1. Brazil Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 9.6.1.2. Brazil Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 9.6.1.3. Brazil Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 9.6.1.4. Brazil Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 9.6.1.5. Brazil Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 9.6.2. Argentina 9.6.2.1. Argentina Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 9.6.2.2. Argentina Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 9.6.2.3. Argentina Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 9.6.2.4. Argentina Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 9.6.2.5. Argentina Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 9.6.3. Rest Of South America 9.6.3.1. Rest Of South America Drug Eluting Balloon Market Size and Forecast, by Product Type (2024-2032) 9.6.3.2. Rest Of South America Drug Eluting Balloon Market Size and Forecast, by Drug Type (2024-2032) 9.6.3.3. Rest Of South America Drug Eluting Balloon Market Size and Forecast, by Technology (2024-2032) 9.6.3.4. Rest Of South America Drug Eluting Balloon Market Size and Forecast, by Application (2024-2032) 9.6.3.5. Rest Of South America Drug Eluting Balloon Market Size and Forecast, by End User (2024-2032) 10. Company Profile: Key Players 10.1. Medtronic, Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Becton, Dickinson and Company 10.3. Boston Scientific Corporation 10.4. Cook Medical Incorporated 10.5. Braun Melsungen AG 10.6. Koninklijke Philips N.V. 10.7. Opto Circuits (India) Limited 10.8. Terumo Corporation 10.9. Surmodics, Inc. 10.10. Biotronik, Inc. 10.11. Concept Medical Inc. 10.12. BIOTRONIK SE & Co. KG 10.13. Innvolution Healthcare Pvt. Ltd. 10.14. Medtronic plc 10.15. Eurocor GmbH 10.16. C.R. Bard 10.17. Aachen Resonance GmbH 11. Key Findings 12. Industry Recommendations 13. Drug Eluting Balloon Market: Research Methodology 14. Terms and Glossary
